Post-ejection thickening as a marker of viable myocardium. An echocardiographic study in patients with chronic coronary artery disease |
| |
Authors: | G. Barletta R. Del Bene P. Lo Sapio C. Gallini F. Fantini |
| |
Affiliation: | (1) Dept. of Internal Medicine and Cardiology University of Florence Via Madaglie d'Oro 43 I-59100 Prato Italy, IT;(2) INRCA-Florence Italy, IT |
| |
Abstract: | Summary The study aim was to assess whether post-ejection thickening (PT) is an useful marker of viable myocardium in patients with chronic coronary artery disease. Twenty-three patients with critical coronary stenoses were submitted to dobutamine and dipyridamole stress-echocardiographies and dipyridamole-early-redistribution 201TI SPECT within 15 days from coronary arteriography. They were selected for the presence of PT in segments that could be optimally studied by M-mode echocardiography and were hypo-akinetic in basal conditons. PT (occurring between end-ejection and mitral valve opening) was found in 58% of dysfunctional critically perfused regions. Ninety-eight percent of the regions with PT and 6% of those without PT improved during low-dose dobutamine stress-echocardiography. Segments with PT had, respectively, higher and lower SPECT early-redistribution thallium activity than dysfunctional segments without PT and normokinetic regions. Therefore, regions with PT were viable and had a moderate decrease in coronary perfusion. Akinetic segments without PT did not show any inotropic reserve. After revascularization almost all the segments with PT improved. In conclusion, PT is a pattern of myocardial contraction easily detected by M-mode echocardiography in the clinical setting. If the results of this study are further confirmed, PT may become a sign for the recognition of myocardial viability. Received: 18 November 1996, Returned for 1. revision: 20 December 1996, 1. Revision received: 30 March 1997, Returned for 2. revison: 21 May 1997, 2. Revision received: 11 August 1997, Returned for 3. revision: 9 September 1997, 3. Revision received: 26 February 1998, Accepted: 25 March 1998 |
| |
Keywords: | Dipyridamole – dobutamine – stress echocardiography – myocardial viability – thallium |
本文献已被 SpringerLink 等数据库收录! |
|